| 2025-02-28 |
详情>>
内部人交易：
Glasener Cletus C等共交易6笔
|
| 2025-02-14 |
详情>>
业绩披露：
2025年一季报每股收益-0.61美元,归母净利润-551.1万美元,同比去年增长2.96%
|
| 2025-01-24 |
股东大会：
将于2025-02-27召开股东大会
会议内容 ▼▲
- 1.Each outstanding restricted stock unit award subject to time-based vesting restrictions, whether vested or unvested, that is outstanding under any of the Company’s 2010 Equity Incentive Plan, 2012 Equity Incentive Plan, Amended and Restated 2019 Equity Incentive Plan, 2022 New Employee Inducement Plan, Officer and Director Share Purchase Plan, Directors’ Compensation Policy, and Short-Term Incentive Plan, in each case, as amended (each a “Company Equity Plan”) will be canceled in consideration for the right to receive a lump sum cash payment (less any applicable tax withholdings) equal to the product obtained by multiplying the amount of the Merger Consideration by the total number of shares of EMCORE common stock represented by such restricted stock unit award subject to time-based vesting restrictions;
2.Each outstanding restricted stock unit award subject to performance vesting conditions that is outstanding under any Company Equity Plan (a) to the extent not vested, will be deemed to have satisfied such performance vesting conditions at 100% of target and will have any time-based vesting conditions waived, and (b) will be canceled in consideration for the right to receive a lump sum cash payment (less any applicable tax withholdings) equal to the product obtained by multiplying the amount of the Merger Consideration by the total number of shares of EMCORE common stock represented by such restricted stock unit award subject to performance vesting conditions;
3.Each outstanding stock option of EMCORE (if any), whether vested or unvested, will be canceled and converted into the right to receive (without interest) a lump sum cash payment (less applicable tax
4.Withholdings) equal to the product obtained by multiplying the excess, if any, of the amount of the Merger Consideration over the per share exercise price of such stock option by the total number of shares of EMCORE common stock underlying such stock option. Any stock option, whether vested or unvested, for which the per share exercise price attributable to such stock option is equal to or greater than the Merger Consideration will be canceled as of the effective time of the Merger for no consideration.
|
| 2025-01-14 |
详情>>
股本变动：
变动后总股本908.08万股
|
| 2025-01-14 |
详情>>
业绩披露：
2024年年报每股收益-3.46美元,归母净利润-3123.8万美元,同比去年增长58.55%
|
| 2024-11-08 |
复牌提示：
2024-11-08 06:55:00 停牌，复牌日期 2024-11-08 07:30:00
|
| 2024-08-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-3.12美元,归母净利润-2813.2万美元,同比去年增长16.72%
|
| 2024-08-06 |
财报披露：
美东时间 2024-08-06 盘后发布财报
|
| 2024-05-14 |
详情>>
业绩披露：
2024年中报每股收益-1.59美元,归母净利润-1417.4万美元,同比去年增长40.75%
|
| 2024-04-02 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2024-02-12 |
详情>>
业绩披露：
2024年一季报每股收益-0.06美元,归母净利润-567.9万美元,同比去年增长51.43%
|
| 2024-01-26 |
股东大会：
将于2024-03-15召开股东大会
会议内容 ▼▲
- 1.To elect the six (6) director nominees named in the attached Proxy Statement to the Board of Directors of the Company (the “Board of Directors”) for a one-year term expiring at the Company’s 2025 Annual Meeting of Shareholders or until their respective successors are duly qualified and elected;
2.To elect the six (6) director nominees named in the attached Proxy Statement to the Board of Directors of the Company (the “Board of Directors”) for a one-year term expiring at the Company’s 2025 Annual Meeting of Shareholders or until their respective successors are duly qualified and elected;
3.To approve, subject to the Board of Directors’ discretion to adopt, an amendment to the Certificate of Incorporation to increase the number of authorized shares of Common Stock from 100,000,000 shares to 150,000,000 shares;
4.To ratify the approval of the Company’s Section 382 Tax Benefits Preservation Plan (the “Section 382 Tax Benefits Preservation Plan”);
5.To approve an amendment to the EMCORE Corporation Amended and Restated 2019 Equity Incentive Plan (the “2019 Equity Incentive Plan”) to increase the number of shares of Common Stock available for issuance under the 2019 Equity Incentive Plan by 7,890,000 shares;
6.To approve, on an advisory basis, the executive compensation of the Company’s named executive officers;
7.To ratify the appointment of CohnReznick LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2024 (“fiscal 2024”);
8.To transact such other business as may properly come before the Annual Meeting and any adjournments or postponements thereof.
|
| 2023-12-27 |
详情>>
业绩披露：
2023年年报每股收益-1.46美元,归母净利润-7535.9万美元,同比去年增长-209.7%
|
| 2023-08-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.74美元,归母净利润-3377.8万美元,同比去年增长-352.79%
|
| 2023-05-10 |
详情>>
业绩披露：
2023年中报每股收益-0.58美元,归母净利润-2392.1万美元,同比去年增长-12756.61%
|
| 2023-02-09 |
详情>>
业绩披露：
2023年一季报每股收益-0.31美元,归母净利润-1169.3万美元,同比去年增长-584.38%
|
| 2023-01-24 |
股东大会：
将于2023-03-10召开股东大会
会议内容 ▼▲
- 1.To elect the five (5) director nominees named in the attached Proxy Statement to the Company’s Board of Directors (our “Board”) for a one-year term expiring at the Company’s 2024 Annual Meeting of Shareholders and until their respective successors are duly qualified and elected;
2.To approve an amendment to the EMCORE Corporation Amended and Restated 2019 Equity Incentive Plan (the “2019 Equity Incentive Plan”) to increase the number of shares of common stock available for issuance under the 2019 Equity Incentive Plan by 1,549,000 shares;
3.To approve on an advisory basis the executive compensation of the Company’s Named Executive Officers;
4.To approve, on an advisory basis, the frequency of votes on the executive compensation of the Company’s Named Executive Officers;
5.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2023;
6.To transact such other business as may properly come before the Annual Meeting and any adjournments or postponements thereof.
|
| 2022-12-28 |
详情>>
业绩披露：
2022年年报每股收益-0.65美元,归母净利润-2433.3万美元,同比去年增长-194.89%
|
| 2022-01-18 |
股东大会：
将于2022-03-11召开股东大会
会议内容 ▼▲
- 1.To elect the five (5) director nominees named in the attached Proxy Statement to the Company’s Board of Directors (our “Board”) for a one-year term expiring at the Company’s 2023 Annual Meeting of Shareholders and until their respective successors are duly qualified and elected;
2.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2022;
3.To approve the Amended and Restated EMCORE Corporation 2019 Equity Incentive Plan (the “Equity Plan”) to increase the number of shares of common stock available for issuance under the Equity Plan by 1.9 million shares;
4.To approve on an advisory basis the executive compensation of the Company’s Named Executive Officers;
5.To transact such other business as may properly come before the Annual Meeting and any adjournments or postponements thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-12 |
股东大会：
将于2021-05-12召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to the EMCORE Corporation Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to authorize an additional 50 million shares of common stock;
2.To approve the adjournments or postponements of the Special Meeting, if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the time of the Special Meeting to approve the proposal above.
|
| 2021-01-21 |
股东大会：
将于2021-03-19召开股东大会
会议内容 ▼▲
- 1.To elect the five (5) director nominees named in the attached Proxy Statement to the Company’s Board of Directors for a one-year term expiring at the Company’s 2022 Annual Meeting of Shareholders and until their respective successors are duly qualified and elected;
2.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2021;
3.To approve the Amended and Restated EMCORE Corporation 2019 Equity Incentive Plan (the “Equity Plan”) to increase the number of shares of common stock available for issuance under the Equity Plan by 2,138,000 shares;
4.To approve on an advisory basis the executive compensation of the Company’s Named Executive Officers;
5.To transact such other business as may properly come before the Annual Meeting and any adjournments or postponements thereof.
|
| 2020-01-22 |
股东大会：
将于2020-03-20召开股东大会
会议内容 ▼▲
- 1.To elect the four (4) director nominees named in the attached Proxy Statement to the Company’s Board of Directors for a one-year term expiring at the Company’s 2021 Annual Meeting of Shareholders and until their respective successors are duly qualified and elected;
2.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2020;
3.To approve on an advisory basis the executive compensation of the Company’s Named Executive Officers;
4.To transact such other business as may properly come before the Annual Meeting and any adjournments or postponements thereof.
|
| 2019-01-24 |
股东大会：
将于2019-03-22召开股东大会
会议内容 ▼▲
- 1.To elect the two (2) director nominees named in the attached Proxy Statement to the Company’s Board of Directors for a one-year term expiring at the Company’s 2020 Annual Meeting of Shareholders and until their respective successors are duly qualified and elected;
2.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2019;
3.To approve the EMCORE Corporation 2019 Equity Incentive Plan, including increasing the number of shares of common stock available for issuance under the Company’s equity plans by 1.796 million shares;
4.To approve on an advisory basis the executive compensation of the Company’s Named Executive Officers;
5.To transact such other business as may properly come before the Annual Meeting and any adjournments or postponements thereof.
|
| 2018-01-18 |
股东大会：
将于2018-03-16召开股东大会
会议内容 ▼▲
- (1)To elect the one (1) director nominee named in the attached Proxy Statement to the Company’s Board of Directors for a three-year term expiring at the Company’s 2021 Annual Meeting of Shareholders and until his successor is duly qualified and elected;
(2)To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2018;
(3)To approve an amendment to the EMCORE Corporation Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to declassify the Company’s Board of Directors;
(4)To approve an amendment to the Certificate of Incorporation to change the required number of members of the Company’s Board of Directors from a minimum of six and a maximum of twelve to a minimum of five and a maximum of nine;
(5)To approve an amendment to the Certificate of Incorporation to eliminate the supermajority voting requirements applicable to certain provisions of the Certificate of Incorporation;
(6)To approve an extension of the Company’s Tax Benefits Preservation Plan;
(7)To approve on an advisory basis the executive compensation of the Company’s Named Executive Officers;
(8)To transact such other business as may properly come before the Annual Meeting and any adjournments or postponements thereof.
|
| 2017-01-25 |
股东大会：
将于2017-03-17召开股东大会
会议内容 ▼▲
- 1.To elect the two (2) director nominees named in the attached Proxy Statement to the Company’s Board of Directors for a three-year term expiring at the Company’s 2020 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified;
2.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2017;
3.To approve certain amendments to the EMCORE Corporation 2012 Equity Incentive Plan, including increasing the number of shares of common stock available for issuance under the plan by 2,400,000 shares;
4.To approve on an advisory basis the executive compensation of the Company’s Named Executive Officers;
5.To approve on an advisory basis the frequency (whether every one, two or three years) of advisory executive compensation votes;
6.To transact such other business as may properly come before the Annual Meeting and any adjournments or postponements thereof.
|
| 2016-07-05 |
除权日：
美东时间 2016-08-01 每股派息1.50美元
|
| 2016-01-22 |
股东大会：
将于2016-03-11召开股东大会
会议内容 ▼▲
- (1)To elect the two (2) director nominees named in the attached Proxy Statement to the Company’s Board of Directors for a three-year term expiring at the Company’s 2019 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified;
(2)To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2016;
(3)To approve on an advisory basis the executive compensation of the Company’s Named Executive Officers;
(4)To approve certain amendments to the EMCORE Corporation 2012 Equity Incentive Plan, including increasing the number of shares of common stock available for issuance under the plan by 500,000 shares;
(5)To transact such other business as may properly come before the Annual Meeting and any adjournments or postponements thereof.
|